Bryce Point Capital LLC Buys New Position in Doximity, Inc. (NASDAQ:DOCS)

Bryce Point Capital LLC purchased a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 11,071 shares of the company's stock, valued at approximately $591,000.

Several other large investors have also recently bought and sold shares of DOCS. Global Retirement Partners LLC lifted its stake in Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after purchasing an additional 440 shares during the period. UMB Bank n.a. raised its position in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after acquiring an additional 235 shares during the last quarter. Larson Financial Group LLC lifted its stake in Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after buying an additional 250 shares during the period. Optimum Investment Advisors acquired a new stake in shares of Doximity in the 4th quarter valued at approximately $43,000. Finally, Morse Asset Management Inc bought a new stake in shares of Doximity in the third quarter worth about $46,000. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently commented on DOCS shares. Wells Fargo & Company restated an "equal weight" rating on shares of Doximity in a report on Friday, February 7th. Piper Sandler upgraded shares of Doximity from a "neutral" rating to an "overweight" rating and increased their price target for the company from $31.00 to $78.00 in a research note on Friday, February 7th. Leerink Partners raised Doximity from a "market perform" rating to an "outperform" rating and raised their price objective for the company from $60.00 to $90.00 in a research report on Friday, February 7th. Needham & Company LLC increased their price objective on shares of Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Finally, Stephens started coverage on shares of Doximity in a research report on Friday, December 20th. They set an "equal weight" rating and a $55.00 price objective for the company. Eleven research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $64.22.

Doximity Trading Up 2.3 %

NASDAQ:DOCS traded up $1.21 during trading hours on Tuesday, hitting $53.60. 774,733 shares of the company were exchanged, compared to its average volume of 1,954,820. The stock has a market capitalization of $10.01 billion, a price-to-earnings ratio of 53.63, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. The company has a fifty day simple moving average of $65.43 and a 200 day simple moving average of $55.21. Doximity, Inc. has a one year low of $22.96 and a one year high of $85.21.

Insider Transactions at Doximity

In other news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at $366,463.20. This trade represents a 75.87 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 37.40% of the company's stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.